Gregory Renza
Stock Analyst at Truist Securities
(3.33)
# 512
Out of 5,182 analysts
253
Total ratings
39.44%
Success rate
5.25%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $818 → $801 | $746.00 | +7.37% | 4 | Mar 31, 2026 | |
| ONC BeOne Medicines AG | Maintains: Buy | $400 → $412 | $320.70 | +28.47% | 4 | Feb 27, 2026 | |
| GILD Gilead Sciences | Maintains: Buy | $145 → $152 | $138.55 | +9.71% | 3 | Feb 11, 2026 | |
| CGON CG Oncology | Maintains: Buy | $66 → $75 | $66.34 | +13.05% | 6 | Feb 10, 2026 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $41 → $40 | $14.66 | +172.85% | 13 | Jan 8, 2026 | |
| AMGN Amgen | Maintains: Hold | $318 → $319 | $349.39 | -8.70% | 19 | Jan 8, 2026 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $59 → $60 | $32.51 | +84.56% | 14 | Jan 6, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $32 → $38 | $34.92 | +8.82% | 8 | Dec 24, 2025 | |
| FULC Fulcrum Therapeutics | Maintains: Buy | $14 → $18 | $7.99 | +125.28% | 5 | Dec 11, 2025 | |
| CATX Perspective Therapeutics | Assumes: Buy | $8 → $12 | $4.26 | +181.69% | 7 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $23 → $30 | $16.69 | +79.75% | 12 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $12.45 | +132.93% | 10 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $4.81 | +128.69% | 7 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $140 | $103.88 | +34.77% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.75 | +227.27% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $10 | $5.14 | +94.55% | 4 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $27.16 | +87.78% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $140 | $122.47 | +14.31% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $45 → $50 | $44.38 | +12.66% | 11 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $26 | $21.25 | +22.38% | 16 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $8 | $4.38 | +82.65% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $5 | $1.16 | +331.03% | 11 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $182 → $172 | $197.83 | -13.06% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $113 → $38 | $67.90 | -44.77% | 14 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $12 | $7.13 | +68.30% | 6 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $14 | $6.34 | +120.82% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $18 | $23.86 | -24.56% | 11 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $68 → $48 | $0.97 | +4,869.46% | 4 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $110 → $20 | $6.19 | +223.10% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $16 | $0.83 | +1,826.55% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $2,160 → $180 | $14.42 | +1,148.27% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $100 → $80 | $0.91 | +8,713.48% | 5 | Mar 16, 2022 |
Regeneron Pharmaceuticals
Mar 31, 2026
Maintains: Buy
Price Target: $818 → $801
Current: $746.00
Upside: +7.37%
BeOne Medicines AG
Feb 27, 2026
Maintains: Buy
Price Target: $400 → $412
Current: $320.70
Upside: +28.47%
Gilead Sciences
Feb 11, 2026
Maintains: Buy
Price Target: $145 → $152
Current: $138.55
Upside: +9.71%
CG Oncology
Feb 10, 2026
Maintains: Buy
Price Target: $66 → $75
Current: $66.34
Upside: +13.05%
Viridian Therapeutics
Jan 8, 2026
Maintains: Buy
Price Target: $41 → $40
Current: $14.66
Upside: +172.85%
Amgen
Jan 8, 2026
Maintains: Hold
Price Target: $318 → $319
Current: $349.39
Upside: -8.70%
IDEAYA Biosciences
Jan 6, 2026
Maintains: Buy
Price Target: $59 → $60
Current: $32.51
Upside: +84.56%
Agios Pharmaceuticals
Dec 24, 2025
Maintains: Buy
Price Target: $32 → $38
Current: $34.92
Upside: +8.82%
Fulcrum Therapeutics
Dec 11, 2025
Maintains: Buy
Price Target: $14 → $18
Current: $7.99
Upside: +125.28%
Perspective Therapeutics
Nov 24, 2025
Assumes: Buy
Price Target: $8 → $12
Current: $4.26
Upside: +181.69%
Nov 24, 2025
Assumes: Buy
Price Target: $23 → $30
Current: $16.69
Upside: +79.75%
Nov 24, 2025
Initiates: Buy
Price Target: $29
Current: $12.45
Upside: +132.93%
Nov 24, 2025
Initiates: Buy
Price Target: $11
Current: $4.81
Upside: +128.69%
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $103.88
Upside: +34.77%
Nov 24, 2025
Initiates: Buy
Price Target: $9
Current: $2.75
Upside: +227.27%
Nov 24, 2025
Initiates: Hold
Price Target: $10
Current: $5.14
Upside: +94.55%
Nov 24, 2025
Initiates: Buy
Price Target: $51
Current: $27.16
Upside: +87.78%
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $122.47
Upside: +14.31%
Jul 8, 2025
Downgrades: Sector Perform
Price Target: $45 → $50
Current: $44.38
Upside: +12.66%
May 19, 2025
Reiterates: Outperform
Price Target: $26
Current: $21.25
Upside: +22.38%
May 15, 2025
Reiterates: Outperform
Price Target: $8
Current: $4.38
Upside: +82.65%
May 14, 2025
Reiterates: Sector Perform
Price Target: $5
Current: $1.16
Upside: +331.03%
May 7, 2025
Maintains: Outperform
Price Target: $182 → $172
Current: $197.83
Upside: -13.06%
Apr 16, 2025
Maintains: Sector Perform
Price Target: $113 → $38
Current: $67.90
Upside: -44.77%
Mar 26, 2025
Reiterates: Outperform
Price Target: $12
Current: $7.13
Upside: +68.30%
Mar 21, 2025
Maintains: Outperform
Price Target: $16 → $14
Current: $6.34
Upside: +120.82%
Jan 14, 2025
Reiterates: Sector Perform
Price Target: $18
Current: $23.86
Upside: -24.56%
Jan 9, 2025
Maintains: Outperform
Price Target: $68 → $48
Current: $0.97
Upside: +4,869.46%
Nov 5, 2024
Downgrades: Sector Perform
Price Target: $110 → $20
Current: $6.19
Upside: +223.10%
Aug 14, 2024
Reiterates: Outperform
Price Target: $16
Current: $0.83
Upside: +1,826.55%
Jun 27, 2023
Downgrades: Sector Perform
Price Target: $2,160 → $180
Current: $14.42
Upside: +1,148.27%
Mar 16, 2022
Maintains: Sector Perform
Price Target: $100 → $80
Current: $0.91
Upside: +8,713.48%